Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other financing activities (2021 - 2023)

Journey Medical's Other financing activities history spans 3 years, with the latest figure at $380000.0 for Q4 2023.

  • For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to $380000.0, compared with a TTM value of $380000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $75000.0, up 50.0% over the prior year.
  • Other financing activities for Q4 2023 was $380000.0 at Journey Medical, up from -$157000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.4 million in Q1 2021, with the low at -$157000.0 in Q3 2022.
  • Average Other financing activities over 3 years is $370000.0, with a median of $214000.0 recorded in 2022.
  • Biggest YoY gain for Other financing activities was 12.29% in 2022; the steepest drop was 133.84% in 2022.
  • Tracing DERM's Other financing activities over 3 years: stood at $464000.0 in 2021, then plummeted by 133.84% to -$157000.0 in 2022, then skyrocketed by 342.04% to $380000.0 in 2023.
  • Per Business Quant, the three most recent readings for DERM's Other financing activities are $380000.0 (Q4 2023), -$157000.0 (Q3 2022), and $157000.0 (Q2 2022).